NEUROCUPLE™ in TKA Patients to Enhance Pain Management

NARecruitingINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

September 25, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2026

Conditions
Total Knee Arthroplasty
Interventions
DEVICE

NEUROCUPLE™ Patch

nCAP Medical has developed an effective, safe, non-opioid alternative, the NEUROCUPLE™ device, based on an innovative nanotechnology to reduce surgical pain and facilitate functional recovery while reducing opioid prescriptions, opioid-related adverse events and reducing the cost of care in millions of Americans undergoing TKA each year.

DEVICE

Placebo Patch

The placebo patch is identical to the active patch but with no active agents.

Trial Locations (1)

15232

RECRUITING

UPMC Shadyside Hospital, Pittsburgh

All Listed Sponsors
collaborator

University of Pittsburgh

OTHER

lead

nCap Medical

INDUSTRY